Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05185037 · ClinicalTrials.gov registry record
NIBP (Non-invasive Blood Pressure) Algorithm Enhancements (Characterize the Robustness of Motion Artifact Suppression)
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Terminated
- Registry status
- 17
- Enrollment target
NCT05185037 is a clinical trial that was terminated before completion, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 17 participants.
The verdict
NCT05185037 was terminated before completion, sponsored by Philips Clinical & Medical Affairs Global.
- TERMINATED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The study intervention consists of a non-invasive blood pressure (NIBP) measurement device and cuff (FDA-cleared Philips IntelliVue X3 Rev. N.04 patient monitor) running a non-approved modified software containing an enhanced measurement algorithm for NIBP.
Interventions
- DEVICE Philips IntelliVue X3 patient monitor with investigational NIBP measurement algorithm (measured once per 3 minutes)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2022-05-26 |
| Est. Completion | 2023-11-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05185037
The ClinicalTrials.gov registry entry for NCT05185037 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Philips IntelliVue X3 patient monitor with investigational NIBP measurement algorithm (measured once per 3 minutes) is the first listed.
NCT05185037 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05185037 about?
NCT05185037 is a clinical study titled "NIBP (Non-invasive Blood Pressure) Algorithm Enhancements (Characterize the Robustness of Motion Artifact Suppression)". The study intervention consists of a non-invasive blood pressure (NIBP) measurement device and cuff (FDA-cleared Philips IntelliVue X3 Rev. N.04 patient monitor) running a non-approved modified software containing an enhanced measurement algorithm for NIBP.
What is the current status of trial NCT05185037?
This trial is currently terminated. The enrollment target is 17 participants. The study started on 2022-05-26. Estimated completion is 2023-11-16.
What interventions are being tested in trial NCT05185037?
The interventions under investigation include: Philips IntelliVue X3 patient monitor with investigational NIBP measurement algorithm (measured once per 3 minutes) (DEVICE).
Who is sponsoring clinical trial NCT05185037?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.